[Nutritional assessment in hospitalized children in a Paediatric service]

Silvia Velandia1, Maria Isabel Hodgson1, Catalina Le Roy1

  • 1Departamento de Gastroenterología y Nutrición Pediátrica, División de Pediatría, Escuela de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.

Insights

Hospitalized children face malnutrition risks, with 8% at nutritional risk and 12.9% exhibiting short stature. Early detection and monitoring are crucial for intervention in pediatric nutritional status.

Area of Science:

  • Pediatric Nutrition
  • Clinical Research
  • Public Health

Background:

  • Malnutrition in hospitalized children is a significant concern, linked to increased morbidity and mortality.
  • Understanding the nutritional status of pediatric hospital patients is essential for effective care.

Purpose of the Study:

  • To assess the nutritional status of children admitted to the Hospital Clínico de la Universidad Católica de Chile.
  • Identify prevalence of undernutrition, overweight, and obesity in pediatric inpatients.

Main Methods:

  • Retrospective, cross-sectional study of 365 children (<17 years) from November 2010 to April 2011.
  • Utilized weight-for-height (WFH) and body mass index (BMI) for nutritional diagnosis, and height-for-age (HFA) for stunted growth assessment.
  • Collected demographic data, admission diagnoses, hospital stay duration, and biochemical markers (albumin, hemoglobin, hematocrit).

Main Results:

  • 3.3% of children were undernourished, 8% were at nutritional risk, 15% overweight, and 10.9% obese.
  • Short stature (HFA ≤-2SD) was reported in 12.9% of the children.
  • Biochemistry results were not significantly associated with nutritional status.

Conclusions:

  • A notable percentage of hospitalized children are at risk of undernutrition.
  • The prevalence of overweight children aligns with the general Chilean pediatric population.
  • Emphasizes the need for early detection, timely intervention, and ongoing nutritional monitoring for pediatric patients.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
647
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360